SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Feb-22 6:09 PM View: | Turning Point Therapeutics,... (TPTX) | 09-Feb-22 | Grant | 16,283 | -- | -- | 73% 22.3K to 38.58K | |
11-Feb-22 6:09 PM View: | Turning Point Therapeutics,... (TPTX) | 09-Feb-22 | Sale | 221 | $36.30 | $8,022.30 | (< 1%) 38.58K to 38.36K | |
15-Jul-21 5:53 PM View: | Turning Point Therapeutics,... (TPTX) | 14-Jul-21 | Market Sale | 1,869 | $74.90 | $139,988.00 | (8%) 23.64K to 21.77K | 7% |
10-Feb-21 5:59 PM View: | Turning Point Therapeutics,... (TPTX) | 08-Feb-21 | Grant | 2,136 | -- | -- | 10% 21.5K to 23.64K | |
14-Jul-20 5:40 PM View: | Turning Point Therapeutics,... (TPTX) | 13-Jul-20 | Grant | 21,500 | -- | -- | 100% 0 to 21.5K |